ReadYourDNA

Desipramine (Norpramin)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Desipramine

What it is

Desipramine is a tricyclic antidepressant (TCA) that acts mostly on noradrenaline. It is used for depression and, off label, for nerve pain and ADHD. It is also the main active breakdown product of imipramine. It is sold as Norpramin, among other names.

How genes come into it

Desipramine is broken down almost entirely by the liver enzyme CYP2D6, so its blood level follows the gene very closely: CYP2D6 poor metabolizers can have several times the usual level, with more side effects, and people with extra copies may have levels too low to work. CPIC has published a guideline on CYP2D6 and the tricyclics, including desipramine, and the US FDA lists an effect on drug levels. A few other genes have been studied, with weaker evidence.

Published guidelines

Clinical guidelines that name a gene for Desipramine. They sort people into groups by the gene copies they carry.

CPIC guideline: CYP2D6. CYP2D6 activity score 0 to 6 or more. Strong. 2017.

US FDA: CYP2D6. CYP2D6 activity score 0 to 6 or more. Data that Demonstrate a Potential Impact on Pharmacokinetic Properties Only.

What research found

Every published finding on gene variants and Desipramine. Upload your DNA file to see which of these rows apply to you.

Rated evidence (5 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CYP2D6 CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10: Level 1A · replicated. Metabolism/PK: Major Depressive Disorder, Mental Disorders. 12.

CYP2D6 CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6: Level 1A · replicated. Toxicity: Depressive Disorder, Major Depressive Disorder. 3.

MC1R rs2228478: Level 3. Efficacy: Major Depressive Disorder. 1.

MC1R rs2228479: Level 3. Efficacy: Major Depressive Disorder. 1.

Metabolism (11 findings)

Studies of how quickly the body processes this medication.

CYP2D6 CYP2D6 poor metabolizer: CYP2D6 poor metabolizer is associated with decreased metabolism of desipramine in healthy individuals as compared to CYP2D6 normal metabolizer.

CYP2D6 CYP2D6 poor metabolizer: CYP2D6 poor metabolizer is associated with decreased clearance of desipramine in healthy individuals as compared to CYP2D6 normal metabolizer.

CYP2D6 CYP2D6 poor metabolizer: CYP2D6 poor metabolizer is associated with decreased clearance of desipramine in healthy individuals as compared to CYP2D6 normal metabolizer.

CYP2D6 CYP2D6 poor metabolizer: CYP2D6 poor metabolizer is associated with decreased metabolism of desipramine in healthy individuals as compared to CYP2D6 normal metabolizer.

Response (1 finding)

Studies of how well it worked in people carrying a variant.

BDNF rs61888800: Genotype GG is associated with increased response to antidepressants, desipramine and fluoxetine in people with Depressive Disorder, Major.

Dosing (1 finding)

Studies of how much of the drug people needed or tolerated.

CYP2D6 CYP2D6 poor metabolizers: CYP2D6 poor metabolizer is associated with decreased dose of desipramine in people with Depressive Disorder, Major as compared to CYP2D6 normal metabolizer.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Amitriptyline (TCAs)

Anafranil (TCAs)

Opipramol (TCAs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com